{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:26:55Z","timestamp":1754152015643,"version":"3.41.2"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/igc.0b013e318299e2a6","type":"journal-article","created":{"date-parts":[[2013,6,21]],"date-time":"2013-06-21T08:46:09Z","timestamp":1371804369000},"page":"1157-1165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Preference-Based Utility Scores for Adverse Events Associated With the Treatment of Gynecologic Cancers"],"prefix":"10.1016","volume":"23","author":[{"given":"Elizabeth L.","family":"Jewell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Smrtka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Broadwater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fidel","family":"Valea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly C.","family":"Nolte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renea","family":"Valea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan R.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura J.","family":"Havrilesky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"1996","series-title":"Cost-effectiveness in Health and Medicine","author":"Gold","key":"10.1097\/IGC.0b013e318299e2a6_bb0005"},{"year":"2005","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","key":"10.1097\/IGC.0b013e318299e2a6_bb0010"},{"key":"10.1097\/IGC.0b013e318299e2a6_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta3090","article-title":"A review of the use of health status measures in economic evaluation","volume":"3","author":"Brazier","year":"1999","journal-title":"Health Technol Assess"},{"key":"10.1097\/IGC.0b013e318299e2a6_bb0020","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jval.2010.11.017","article-title":"Utility scores and treatment preferences for clinical early-stage cervical cancer","volume":"14","author":"Jewell","year":"2011","journal-title":"Value Health"},{"key":"10.1097\/IGC.0b013e318299e2a6_bb0025","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ygyno.2008.12.026","article-title":"Determination of quality of lifeYrelated utilities for health states relevant to ovarian cancer diagnosis and treatment","volume":"113","author":"Havrilesky","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1097\/IGC.0b013e318299e2a6_bb0030","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1006\/gyno.2002.6807","article-title":"Patient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time?","volume":"87","author":"Sun","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1097\/IGC.0b013e318299e2a6_bb0035","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1200\/JCO.2009.22.3529","volume":"27","author":"Kornblith","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1097\/IGC.0b013e318299e2a6_bb0040","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1200\/JCO.2006.07.3494","article-title":"Health-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: a Gynecologic Oncology Group Study","volume":"25","author":"Wenzel","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1097\/IGC.0b013e318299e2a6_bb0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11136-006-9003-5","article-title":"Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: a gynecologic oncology group study","volume":"16","author":"Bruner","year":"2007","journal-title":"Qual Life Res"},{"key":"10.1097\/IGC.0b013e318299e2a6_bb0050","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/S0022-5347(05)65099-9","article-title":"Patient preferences for outcomes associated with surgical management of prostate cancer","volume":"167","author":"Smith","year":"2002","journal-title":"J Urol"},{"key":"10.1097\/IGC.0b013e318299e2a6_bb0055","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1008850610569","article-title":"A multi-attribute model of prostate cancer patient's preferences for health states","volume":"8","author":"Chapman","year":"1999","journal-title":"Qual Life Res"},{"key":"10.1097\/IGC.0b013e318299e2a6_bb0060","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jamcollsurg.2009.12.004","article-title":"Quantitative weighting of postoperative complications based on the accordion severity grading system: demonstration of potential impact using the American College of Surgeons National Surgical Quality Improvement Program","volume":"210","author":"Porembka","year":"2010","journal-title":"J Am Coll Surg"},{"key":"10.1097\/IGC.0b013e318299e2a6_bb0065","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/gyno.1998.5189","article-title":"Perceptions of cisplatin-related toxicities among ovarian cancer patients and gynecologic oncologists","volume":"71","author":"Calhoun","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1097\/IGC.0b013e318299e2a6_bb0070","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/sj.bjc.6603326","article-title":"Health state utilities for metastatic breast cancer","volume":"95","author":"Lloyd","year":"2006","journal-title":"Brit J Cancer"},{"key":"10.1097\/IGC.0b013e318299e2a6_bb0075","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1006\/gyno.1997.4786","article-title":"Cost-utility analysis of paclitaxel in combination with cisplatin for patients with advanced ovarian cancer","volume":"66","author":"Ortega","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1097\/IGC.0b013e318299e2a6_bb0080","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/(SICI)1097-0142(20000315)88:6<1294::AID-CNCR4>3.0.CO;2-M","article-title":"Quality of life in survivors of colorectal carcinoma","volume":"88","author":"Ramsey","year":"2000","journal-title":"Cancer"},{"key":"10.1097\/IGC.0b013e318299e2a6_bb0085","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejca.2006.09.007","article-title":"Putting the 'Q' in quality adjusted life years (QALYs) for advanced ovarian cancerVan approach using data clustering methods and the internet","volume":"43","author":"Stein","year":"2007","journal-title":"EurJ Cancer"},{"key":"10.1097\/IGC.0b013e318299e2a6_bb0090","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/01.mlr.0000156862.33341.45","article-title":"Utilities for prostate cancer health states in men aged 60 and older","volume":"43","author":"Stewart","year":"2005","journal-title":"Med Care"},{"key":"10.1097\/IGC.0b013e318299e2a6_bb0095","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2008.20.2424","article-title":"Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial","volume":"27","author":"Nout","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1097\/IGC.0b013e318299e2a6_bb0100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/SLA.0b013e3181afde41","article-title":"The accordion severity grading system of surgical complications","volume":"250","author":"Strasberg","year":"2009","journal-title":"Ann Surg"},{"key":"10.1097\/IGC.0b013e318299e2a6_bb0105","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ygyno.2007.08.056","article-title":"Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis","volume":"107","author":"Jewell","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1097\/IGC.0b013e318299e2a6_bb0110","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ygyno.2007.04.015","article-title":"Cost-effectiveness of adjuvant radiotherapy in intermediate risk endometrial cancer","volume":"106","author":"Rankins","year":"2007","journal-title":"Gynecol Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24087620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24087620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T12:36:04Z","timestamp":1753101364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24087620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1048891X24087620"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e318299e2a6","relation":{},"ISSN":["1048-891X"],"issn-type":[{"type":"print","value":"1048-891X"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preference-Based Utility Scores for Adverse Events Associated With the Treatment of Gynecologic Cancers","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e318299e2a6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2013 by IGCS and ESGO.","name":"copyright","label":"Copyright"}]}}